APA

Zucali P. A., Simonelli M., De Vincenzo F., Lorenzi E., Perrino M., Bertossi M., Finotto R., Naimo S., Balzarini L., Bonifacio C., Timofeeva I., Rossoni G., Mazzola G., Lambiase A., Bordignon C. & Santoro A. (20130307). Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours. : British journal of cancer.

Chicago

Zucali P A, Simonelli M, De Vincenzo F, Lorenzi E, Perrino M, Bertossi M, Finotto R, Naimo S, Balzarini L, Bonifacio C, Timofeeva I, Rossoni G, Mazzola G, Lambiase A, Bordignon C and Santoro A. 20130307. Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours. : British journal of cancer.

Harvard

Zucali P. A., Simonelli M., De Vincenzo F., Lorenzi E., Perrino M., Bertossi M., Finotto R., Naimo S., Balzarini L., Bonifacio C., Timofeeva I., Rossoni G., Mazzola G., Lambiase A., Bordignon C. and Santoro A. (20130307). Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours. : British journal of cancer.

MLA

Zucali P A, Simonelli M, De Vincenzo F, Lorenzi E, Perrino M, Bertossi M, Finotto R, Naimo S, Balzarini L, Bonifacio C, Timofeeva I, Rossoni G, Mazzola G, Lambiase A, Bordignon C and Santoro A. Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours. : British journal of cancer. 20130307.